CrystalGenomics has newly appeared among the top searched stocks.


As of 2:31 PM on the 12th, CrystalGenomics is trading at 16,600 KRW, up 2.15% from the previous day. This marks a 24.34% increase compared to February 24. CrystalGenomics is known as a specialized company in new drug development, including treatments for arthritis and novel antibiotics.

Today, foreigners have sold a net 21,407 shares of CrystalGenomics, while institutions have bought a net 7,000 shares, according to provisional data. Over the past five days, individual investors have sold a net 158,116 shares, while foreigners and institutions have bought net 144,265 shares and 17,964 shares, respectively.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing